RHDV2 (newer variant)

RHDV2, also known as Rabbit Hemorrhagic Disease Virus Type 2 or new variant VHD, represents the more recently emerged and now globally dominant strain of rabbit hemorrhagic disease virus. First identified in France in 2010, RHDV2 has since spread to nearly every continent and has displaced the classic RHDV1 strain in many regions. This highly lethal calicivirus causes acute fatal disease characterized by liver necrosis and disseminated intravascular coagulation, killing affected rabbits within hours to days of infection. A critical distinction from the classic RHDV1 strain is that RHDV2 can cause fatal disease in rabbits of all ages, including young kits that were previously protected from RHDV1. Additionally, RHDV2 has demonstrated ability to infect wild lagomorph species beyond domestic rabbits, including hares, jackrabbits, and cottontail rabbits, making it a significant concern for wildlife conservation.

RHDV2 arrived in the United States in 2018 with isolated cases in domestic rabbits, followed by a major outbreak beginning in March 2020 that affected both wild and domestic rabbits across the western states. Since then, RHDV2 has become endemic in the western United States, with cases reported in numerous states and ongoing spread. The virus has been detected in wild jackrabbits, cottontail rabbits, and feral domestic rabbits, establishing a wildlife reservoir that makes eradication essentially impossible. This endemic status means that all rabbit owners in affected regions and increasingly across the country must take preventive measures seriously. The Medgene RHDV2 vaccine received USDA emergency use authorization in 2021, providing domestic rabbits with effective protection against this devastating disease.

The impact of RHDV2 extends beyond pet rabbits to affect commercial rabbit operations, rescue organizations, wild rabbit populations, and species of conservation concern. Mortality rates in affected populations range from 40 to 80 percent in wild rabbits and may reach 100 percent in domestic rabbit facilities, devastating entire herds within days of disease introduction. The virus spreads through direct contact between rabbits, contaminated materials and environments, and mechanical vectors including insects. RHDV2 demonstrates exceptional environmental stability, surviving for months in dried biological material and contaminated surfaces, which contributes to its efficient spread and persistence. The broader host range of RHDV2 compared to RHDV1 has raised concerns for wild lagomorph populations including threatened species such as the pygmy rabbit.

There is no treatment for RHDV2 infection once clinical signs develop, making prevention through vaccination the only reliable protection. The Medgene vaccine available in the United States requires two doses administered 21 days apart for initial immunity, with annual boosters to maintain protection. Vaccination should be considered essential for all pet rabbits, particularly those in endemic areas or with any potential exposure to wild rabbits, outdoor environments, or other risk factors. Additionally, strict biosecurity measures including indoor housing, insect control, and careful hygiene practices reduce exposure risk. Rabbit owners should work closely with rabbit-savvy veterinarians to implement comprehensive prevention strategies that protect their rabbits from this serious threat.

RHDV2 is caused by infection with rabbit hemorrhagic disease virus type 2, classified as genotype GI.2 within the Lagovirus genus of the Caliciviridae family. This non-enveloped, single-stranded RNA virus emerged as a distinct variant from the classic RHDV1 strain, with significant genetic and antigenic differences that prevent cross-protection between the two types. RHDV2 primarily targets hepatocytes in the liver, causing massive cell death and triggering the cascade of organ failure and hemorrhaging that characterizes the disease. The virus replicates rapidly once it enters a susceptible host, overwhelming the immune system before effective defenses can be mounted. This rapid replication combined with efficient transmission makes RHDV2 one of the most devastating infectious diseases affecting domestic and wild rabbits.

Unlike the classic RHDV1 strain, RHDV2 does not demonstrate age-related resistance—rabbits of all ages from nursing kits to elderly adults are fully susceptible to fatal infection. This represents a critical difference that makes RHDV2 more dangerous to rabbit populations overall. Young rabbits that would have survived RHDV1 exposure due to maternal antibody protection or developmental factors succumb to RHDV2 at similar rates as adults. The absence of a protected age class means that entire populations including breeding does and their litters can be affected simultaneously. No genetic or hereditary factors within rabbits affect susceptibility; all domestic rabbits (Oryctolagus cuniculus) and numerous wild lagomorph species are equally vulnerable to infection.

Environmental factors critically influence RHDV2 transmission and persistence. The virus demonstrates remarkable stability outside the host, remaining infectious for three months or longer in decomposing carcasses, dried biological material, and contaminated surfaces. It survives freezing temperatures and persists in rabbit products including meat, fur, and pelts. Transmission occurs through multiple routes including direct contact between infected and susceptible rabbits through oral, nasal, and conjunctival exposure. Indirect transmission through fomites is extremely efficient, with the virus spreading via contaminated food, water, bedding, cages, clothing, shoes, and equipment. Insects including flies, mosquitoes, and fleas serve as mechanical vectors, carrying viral particles on their bodies and legs. Wild rabbits, rodents, predators, and scavengers can spread contaminated material between locations.

Risk factors for RHDV2 infection center on exposure opportunities. Geographic location matters significantly, with rabbits in western states where RHDV2 is endemic facing higher ongoing risk than those in areas without confirmed cases. Outdoor housing dramatically increases exposure risk through contact with wild rabbits, contaminated environments, and insect vectors. Multi-rabbit facilities face amplified risk because a single introduction can spread rapidly through the population. Attendance at rabbit shows or other gatherings increases exposure through contact with rabbits of unknown health status. Purchasing hay, vegetables, or supplies from affected areas may introduce contaminated materials. Contact with wild rabbits or areas they frequent poses direct transmission risk. Unvaccinated rabbits in any setting represent the highest-risk category.

The mechanism of RHDV2 disease involves devastatingly efficient targeting of the liver. After entering through oral or nasal routes, the virus travels through the bloodstream to hepatocytes, where it begins aggressive replication. Within 24 to 72 hours, massive numbers of liver cells die, releasing cellular contents and triggering systemic inflammatory response. This liver destruction initiates disseminated intravascular coagulation (DIC), where abnormal clotting throughout the microvasculature consumes platelets and clotting factors until the blood can no longer clot effectively. The result is simultaneous thrombosis in small vessels causing organ damage and uncontrolled hemorrhaging from multiple sites. Impaired liver function prevents normal toxin clearance and clotting factor production, accelerating multi-organ failure. Death typically occurs within 12 to 72 hours of symptoms appearing, though many rabbits die in the peracute form without showing any symptoms at all.

The most common and distressing presentation of RHDV2 infection is sudden death without any preceding clinical signs. In this peracute form, which represents the majority of cases, owners discover their apparently healthy rabbit deceased without any warning. The only evidence of illness may be blood visible around the nose or mouth, often noticed only after death. This sudden presentation occurs because RHDV2 causes such rapid organ destruction that death precedes symptom development. Rabbits may appear completely normal in the morning and be found dead hours later. This reality is particularly traumatic for owners and underscores that vaccination is the only reliable protection—once infection occurs, there is typically no opportunity for diagnosis or treatment. Understanding that RHDV2 kills without warning is essential for appreciating why prevention must be the priority.

In rabbits that survive long enough to develop observable signs, acute RHDV2 presents with nonspecific symptoms that progress rapidly over 12 to 36 hours. Early signs may include lethargy, quietness, and reduced responsiveness. The rabbit may sit hunched in one location showing reluctance to move or engage normally. Fever may be present initially but often drops to subnormal as shock develops. Complete loss of appetite is typical, with affected rabbits refusing all food and water. In rabbits, not eating for 12 hours or more is always an emergency requiring immediate veterinary attention due to their need for continuous gut motility. However, by the time appetite loss is noticed in RHDV2, the disease has usually progressed beyond any meaningful intervention. Some rabbits show respiratory signs including labored breathing, increased respiratory rate, and nasal discharge.

Behavioral changes in RHDV2-infected rabbits reflect severe systemic illness but must be interpreted knowing that rabbits instinctively hide illness as a prey animal survival mechanism. Affected rabbits may isolate themselves from bonded companions, seeking hiding spots away from normal activity. They typically appear depressed and withdrawn, lacking normal personality and responses. Teeth grinding (bruxism) indicates pain or significant discomfort. Posture changes including hunching with the abdomen held tight suggest abdominal pain from liver involvement. Activity decreases dramatically, with rabbits reluctant or unable to hop. Some rabbits display abnormal positions or press their heads against surfaces. Because rabbits mask illness until they can no longer maintain appearances, any observable change in behavior warrants immediate concern and veterinary contact.

Physical signs of RHDV2 infection reflect the massive internal organ damage and hemorrhaging. Hemorrhaging may be visible as blood-tinged or frankly bloody discharge from the nose, mouth, eyes, or rectum. The ears and other hairless skin areas may show petechiae—small red spots indicating bleeding under the skin. Jaundice manifested as yellow discoloration of the ears, gums, and whites of the eyes indicates liver failure and may be visible in rabbits surviving longer than 24 hours. Respiratory distress including labored breathing, rapid shallow respirations, and cyanosis (blue-tinged membranes from poor oxygenation) occurs frequently. Because rabbits are obligate nasal breathers, any open-mouth breathing represents a dire emergency. Neurological signs including disorientation, weakness, circling, head pressing, seizures, and collapse may occur in later stages.

Symptom progression in acute RHDV2 follows a devastatingly rapid course. Initial subtle changes progress within hours to obvious illness including complete anorexia, severe lethargy, and respiratory compromise. Affected rabbits become progressively weaker and less responsive, eventually becoming recumbent and unable to rise or reposition themselves. Body temperature drops as circulation fails and shock ensues. Hemorrhaging may become more pronounced in terminal stages, with blood appearing around the nose and mouth. Final stages may include collapse, coma, seizures, and opisthotonus (severe muscle spasm causing the head to arch backward). Some rabbits emit a terminal cry before death. The entire course from first symptoms to death typically spans 12 to 36 hours, though death may occur much faster or extend slightly longer in individual cases.

Emergency symptoms demanding immediate action include any bleeding from body orifices; sudden collapse or inability to stand; severe respiratory distress or open-mouth breathing; seizures or severe neurological signs; complete refusal to eat lasting more than 12 hours; and sudden death of any companion rabbit. If RHDV2 is suspected, immediately isolate the affected rabbit from other rabbits to prevent transmission. Contact your veterinarian before transport to allow preparation of biosecurity measures. In multi-rabbit households where sudden death occurs, all other rabbits must be considered potentially exposed and should be monitored closely while consulting your veterinarian about emergency vaccination. The highly contagious nature of RHDV2 means exposed rabbits may already be infected even if appearing healthy.

Diagnosing RHDV2 in living rabbits presents extreme challenges because the disease progresses so rapidly that most affected animals die before meaningful diagnostic workup can be completed. When a rabbit presents with clinical signs suggestive of RHDV2, the veterinarian will perform a thorough physical examination assessing vital signs, level of consciousness, evidence of hemorrhaging, and overall condition. Findings are often nonspecific and cannot definitively distinguish RHDV2 from other causes of rapid decline. History is crucial and should include detailed information about vaccination status, potential exposure to other rabbits or wild lagomorphs, recent purchases of rabbits or supplies, housing situation (indoor vs outdoor), and any recent deaths among companion rabbits or wild rabbits in the area. A rabbit-savvy veterinarian with exotic animal experience is essential for appropriate evaluation.

Laboratory testing supports RHDV2 diagnosis but results often come too late to affect individual patient outcomes. Blood work may reveal abnormalities consistent with hepatic failure and coagulopathy including markedly elevated liver enzymes (ALT, AST, GGT), elevated bilirubin, prolonged clotting times (PT, PTT), low platelet counts, and evidence of disseminated intravascular coagulation. Chemistry panels may show electrolyte derangements and markers of multi-organ dysfunction. Anemia may be present from hemorrhage. However, these findings are not specific to RHDV2 and occur with other causes of liver failure. Definitive diagnosis requires PCR (polymerase chain reaction) testing to detect viral RNA in blood, liver tissue, or other samples. This testing differentiates RHDV2 from RHDV1 and is performed at state veterinary diagnostic laboratories or specialized facilities.

Differential diagnosis is important for distinguishing RHDV2 from other conditions causing sudden death or rapid decline in rabbits. RHDV1 causes identical clinical disease but typically spares young rabbits. Myxomatosis in peracute form can cause rapid death with some similar features. Pasteurellosis can progress to septicemia and death. Heat stroke causes sudden collapse and may include hemorrhagic components. Various toxicoses from poisonous plants, rodenticides, or chemicals cause liver damage and hemorrhaging. Acute GI stasis with hepatic lipidosis can cause death over several days. Trauma causing internal hemorrhage should be considered. Notably, RHDV2 affects rabbits of all ages including young kits, while RHDV1 primarily kills adults—this age pattern can help differentiate between strains during outbreaks. Multiple deaths occurring rapidly across age groups strongly suggests RHDV2.

Definitive diagnosis of RHDV2 typically occurs postmortem through necropsy and laboratory testing. Characteristic necropsy findings include an enlarged, pale, or mottled liver with extensive necrosis; an enlarged congested spleen; hemorrhages visible throughout multiple organs including lungs, heart, and kidneys; and bloody fluid in body cavities. Histopathology reveals acute hepatic necrosis with characteristic viral changes. Liver and spleen tissue samples submitted for PCR testing confirm RHDV presence and identify the specific genotype (GI.2 for RHDV2). If your rabbit dies suddenly and RHDV2 is suspected, refrigerate the body (do not freeze if possible) and contact your veterinarian about submitting it for diagnostic testing. This information is critical for outbreak tracking, protecting remaining rabbits, and alerting authorities to disease presence in the area. RHDV2 is a reportable disease, and confirmed cases trigger surveillance and response activities by animal health authorities.

No specific treatment or cure exists for RHDV2 infection. The virus causes catastrophic organ damage so rapidly that meaningful therapeutic intervention is essentially impossible once clinical signs develop. No antiviral medications effective against RHDV2 have been developed, and the precipitous disease course prevents immune system response from controlling infection. This reality makes vaccination absolutely essential as the only reliable means of protection. For owners facing a suspected RHDV2 case, the focus must shift from curative treatment to supportive comfort care, biosecurity to protect other rabbits, and honest assessment of prognosis that typically points toward humane euthanasia as the most compassionate option.

In the rare circumstance that a rabbit with suspected RHDV2 presents while still alive and not in extremis, intensive supportive care represents the only treatment option. This includes aggressive fluid therapy through intravenous or subcutaneous routes to support circulation and address dehydration; thermal support to maintain body temperature as shock progresses; supplemental oxygen for respiratory distress; pain management using rabbit-safe analgesics such as meloxicam or buprenorphine; and nutritional support through syringe feeding of critical care formula if the rabbit can safely swallow. Gut motility support may be considered given the risk of GI stasis secondary to anorexia. However, it must be clearly stated that such interventions very rarely succeed in changing outcomes—the overwhelming majority of rabbits with clinical RHDV2 will die from the disease regardless of treatment intensity.

Surgical intervention has no role in treating RHDV2 as this is a systemic viral infection causing multi-organ failure that cannot be addressed surgically. Any anesthetic procedure in a rabbit with suspected RHDV2 carries extreme risk due to liver failure impairing drug metabolism, coagulopathy increasing bleeding complications, and overall systemic compromise. Rabbit anesthesia already involves elevated risk compared to dogs and cats, and these risks become prohibitive in the context of acute hepatic necrosis. The principle that rabbits should not be fasted before anesthesia becomes irrelevant as affected rabbits are already anorexic from disease.

Supportive and palliative care for rabbits suspected to have RHDV2 prioritizes comfort over cure. House the rabbit in a quiet, warm, stress-free environment completely isolated from other rabbits to prevent transmission. Minimize handling and disturbance while providing gentle support. Use absorbent bedding changed as needed if hemorrhaging occurs. Offer water and favorite foods though most affected rabbits refuse both. Critical care formula may be offered via syringe if the rabbit accepts it. Pain medication prescribed by your veterinarian helps manage discomfort during what is typically a terminal illness. Keep the environment calm and peaceful. Strict isolation from all other rabbits is absolutely essential given the highly contagious nature of RHDV2.

Alternative treatments and complementary therapies have no proven efficacy against RHDV2 and pursuing them wastes precious time while potentially prolonging suffering. No herbal remedies, homeopathic preparations, or nutritional supplements can combat acute viral hepatic necrosis. Given the rapid fatal course of RHDV2 infection, humane euthanasia is typically the most compassionate choice for rabbits showing clinical signs. This allows a peaceful death rather than the distressing terminal stages of hemorrhagic disease.

Treatment decisions in suspected RHDV2 cases require honest assessment of realities. Survival rates for rabbits with clinical RHDV2 infection approach zero, making intensive treatment efforts futile in most cases. The distress and discomfort of the dying process argue strongly for humane euthanasia when diagnosis is confident. For exposed but apparently healthy rabbits in the household, emergency vaccination may be recommended by your veterinarian—while this cannot help rabbits already infected, it may protect those not yet infected if administered before virus reaches them. Strict biosecurity, environmental disinfection, and monitoring of survivors are essential following any suspected RHDV2 case. The focus must be on protecting remaining rabbits through vaccination and prevention rather than attempting to treat an untreatable disease.

Recovery from RHDV2 infection is extremely rare, with mortality rates ranging from 40 to 80 percent in wild rabbit populations and potentially reaching 100 percent in domestic rabbit facilities. The small percentage of rabbits that survive may do so due to lower viral dose exposure, partial immunity from prior contact with related non-pathogenic caliciviruses, or exposure to naturally attenuated viral variants with reduced virulence. For the exceptional rabbit that survives acute RHDV2 infection, the recovery period extends over weeks to months as damaged liver tissue regenerates and other organ systems heal. These survivors require careful monitoring, nutritional support, and protection from secondary complications throughout their recovery.

Post-infection care for RHDV2 survivors emphasizes supporting liver regeneration and preventing complications. Diet should consist of unlimited high-quality grass hay to maintain gut function, limited pellets, and appropriate fresh leafy greens. Hydration must be monitored carefully with subcutaneous fluids administered if the rabbit is not drinking adequately. Medications metabolized by the liver should be avoided when possible until function normalizes. Regular veterinary rechecks including blood work to assess liver enzymes and clotting function are essential during recovery. The rabbit should be housed in a clean, quiet, low-stress environment with easy access to food, water, and litter box. Any signs of GI stasis, a common secondary complication in sick rabbits, must be addressed immediately.

Factors influencing prognosis in the rare RHDV2 survivors include the severity of initial infection, extent of hepatic damage sustained, the rabbit's age and baseline health status, and quality of supportive care during recovery. Rabbits that maintained some level of appetite and mobility during acute illness generally have better outcomes than those that became completely debilitated. Concurrent health issues such as dental disease or pre-existing conditions complicate recovery. The presence of deep pain response and maintained consciousness during acute illness are relatively favorable prognostic indicators, though even rabbits with these signs usually succumb to RHDV2. Early recognition and initiation of supportive care may marginally benefit the small minority capable of surviving.

Long-term outlook for the rare RHDV2 survivors is generally positive once the acute phase is past. Survivors appear to develop immunity to RHDV2, though this protection may not extend to RHDV1, which is immunologically distinct. Vaccination recommendations for survivors should be discussed with the veterinarian, particularly in areas where both viral strains circulate. Some survivors may have residual liver damage that could predispose them to hepatic issues later in life, making periodic liver function monitoring advisable. Critically, recovered rabbits can shed virus in feces and secretions for an extended period—potentially 30 days or longer—and must remain strictly isolated from unvaccinated rabbits during this time to prevent transmission. Only when shedding has ceased can survivors safely rejoin unvaccinated companions, though ideally all rabbits should be vaccinated.

Vaccination is the cornerstone of RHDV2 prevention and should be considered essential for all domestic rabbits, particularly in endemic areas. In the United States, the Medgene RHDV2 vaccine has been available under USDA emergency use authorization since October 2021. This killed recombinant vaccine requires two doses administered 21 days apart for initial immunity—a single dose does not provide protection. Annual booster vaccinations maintain immunity after the initial series. Vaccination can begin once rabbits reach appropriate age, typically around 4-6 weeks, though specific protocols should be discussed with your veterinarian. In Europe and other regions, additional RHDV2 vaccines are available, some as combination products also covering RHDV1 and myxomatosis. Consult with a rabbit-savvy veterinarian to determine appropriate vaccination protocols for your geographic area and situation.

Biosecurity measures provide essential protection beyond vaccination. Keep pet rabbits housed indoors to eliminate exposure to wild rabbits, contaminated environments, and insect vectors. Indoor-only housing dramatically reduces RHDV2 risk compared to outdoor or partially outdoor arrangements. If outdoor housing is unavoidable, elevate hutches off the ground and implement comprehensive insect and rodent control programs. Never allow pet rabbits to graze on outdoor grass, contact areas frequented by wild rabbits, or consume foraged plants. Remove outdoor shoes before entering areas where rabbits are kept, or maintain dedicated indoor footwear. Wash hands thoroughly before and after handling rabbits. Quarantine any new rabbits for a minimum of 30 days before introduction to existing pets, and require proof of RHDV2 vaccination before accepting new animals.

Dietary precautions reduce risk of introducing RHDV2 through contaminated materials. Purchase hay from reputable suppliers, ideally from regions without active outbreaks. Hay stored for at least three months is considered safer than freshly harvested hay, as viral contamination becomes inactive over time. Store hay and food supplies indoors in sealed containers protected from insects and rodent contamination. Avoid feeding any wild-foraged greens or plants that may have contacted wild rabbit droppings. Commercially grown greenhouse vegetables are safer than field-grown produce from endemic areas. Rinse all vegetables thoroughly before feeding, though this cannot guarantee elimination of viral contamination if present.

Ongoing health maintenance supports prevention efforts. Establish a relationship with a rabbit-savvy veterinarian who can advise on RHDV2 risk in your area and appropriate vaccination schedules. Keep vaccination records current and maintain annual booster schedules faithfully. Monitor your rabbit daily for any changes in appetite, behavior, or activity, keeping in mind that rabbits hide illness. Track food and water intake along with fecal output to establish normal baselines. Avoid taking rabbits to shows, fairs, or gatherings where they may contact unfamiliar rabbits, particularly during active outbreaks. Stay informed about RHDV2 case reports in your region through state veterinary and wildlife agencies.

Early warning awareness and rapid response help limit outbreak impact when RHDV2 is detected. Know the signs of RHDV2 even though sudden death without warning is the most common presentation. Any unexplained death in a rabbit should prompt consideration of RHDV2, especially if the rabbit was unvaccinated or if wild rabbit deaths have occurred in the area. Report suspected cases to your veterinarian and state animal health authorities for appropriate surveillance response. In multi-rabbit households where RHDV2 is suspected, immediately isolate remaining rabbits and consult your veterinarian about emergency vaccination of apparently healthy rabbits. Thoroughly disinfect all housing, equipment, and areas contacted by the affected rabbit using appropriate virucidal disinfectants. Properly dispose of deceased rabbits according to veterinary guidance to prevent environmental contamination and spread to wild populations.

Daily management for rabbits in RHDV2-endemic areas requires consistent biosecurity practices integrated into regular care routines. Establish habits of removing outdoor footwear before entering areas where rabbits are housed and washing hands thoroughly before and after any rabbit contact. Feed only commercial hay, quality pellets, and store-bought vegetables rather than any foraged items. Monitor your rabbit closely each day for changes in appetite, energy level, behavior, and overall condition, keeping in mind that rabbits instinctively hide illness and subtle changes may indicate serious problems. Check litter box output regularly, as changes in fecal pellet production, size, or consistency can signal developing health issues. For multi-rabbit households, observe social interactions for signs of one rabbit isolating or being avoided by companions, which may indicate illness.

Environmental management serves both disease prevention and general rabbit health. Indoor-only housing eliminates the major exposure routes for RHDV2 and is strongly recommended in endemic areas. Maintain rabbit living spaces in quiet areas away from temperature extremes and drafts while ensuring good ventilation. Keep temperatures comfortable between 60 and 70 degrees Fahrenheit, as heat stress can compromise immune function. Implement insect control including screens on windows and doors, elimination of standing water where mosquitoes breed, and rabbit-safe fly control methods. Maintain effective rodent exclusion using methods that cannot poison your rabbit. Clean and disinfect housing and equipment regularly using rabbit-safe products. If you must go to areas with wild rabbits or other potentially infected environments, change clothes and shoes before returning to your rabbits.

Maintaining quality of life within biosecurity constraints requires thoughtful balance. While limiting outdoor exposure is essential for disease prevention, rabbits still need adequate exercise, mental stimulation, and social companionship for wellbeing. Provide a large indoor exercise space or rabbit-proofed room for hopping, binkying, and exploration. Offer enrichment through appropriate toys, tunnels, cardboard boxes, and novel items to investigate. Maintain bonded pairs or groups together, as social relationships are important for rabbit wellbeing. Spend quality time interacting with your rabbit through grooming, gentle play, and quiet companionship. Ensure continuous access to unlimited grass hay, which supports both dental and digestive health while providing natural foraging behavior opportunities.

Ongoing monitoring and veterinary partnership remain essential for rabbits in RHDV2-endemic regions. Schedule wellness examinations with a rabbit-savvy veterinarian every six to twelve months for healthy adults, more frequently for seniors or rabbits with health issues. Keep RHDV2 vaccinations current with timely annual boosters—mark your calendar and set reminders to ensure boosters are not delayed. Monitor body weight weekly using a kitchen or postal scale, as weight changes often signal developing problems before other signs appear. Track daily food and water consumption to recognize changes early. If any rabbit in your household dies unexpectedly, consult your veterinarian about postmortem examination to determine cause of death, as this information protects remaining rabbits and the broader community.

Owner resources and community support strengthen your ability to protect rabbits from RHDV2. The House Rabbit Society and local rabbit rescue organizations provide education about disease prevention and general rabbit care. Online communities allow rabbit owners to share information about local outbreaks, vaccine availability, and veterinary resources. Maintain contact with your veterinarian's office for updates on regional disease activity and vaccine supplies. Consider the financial aspects of rabbit ownership including vaccination costs, quality housing and supplies, and emergency veterinary care budget. Having resources and plans in place for both routine care and emergencies ensures optimal protection for your rabbits. While RHDV2 is a frightening disease, consistent vaccination combined with biosecurity practices dramatically reduces risk, allowing you to enjoy your bond with your rabbits with greater confidence.

RHDV2 affects all domestic rabbit breeds equally—susceptibility is determined by species rather than breed characteristics. Every breed of domestic European rabbit (Oryctolagus cuniculus) is fully susceptible to fatal RHDV2 infection if unvaccinated. This includes all common pet breeds from small varieties like Netherland Dwarfs, Holland Lops, Mini Rex, and Lionheads to medium breeds such as Dutch, English Spot, and Florida White to large breeds including Flemish Giants, French Lops, and New Zealand Whites. Mixed breed rabbits are equally at risk. A critical distinction from RHDV1 is that RHDV2 affects rabbits of all ages—young kits that would have been protected from RHDV1 by maternal antibodies are fully susceptible to fatal RHDV2 infection. Additionally, RHDV2 has demonstrated ability to infect wild lagomorph species including hares (Lepus species), jackrabbits, cottontail rabbits (Sylvilagus species), and even pygmy rabbits.

Certain populations face elevated risk based on management and exposure factors. Unvaccinated rabbits constitute the highest-risk category regardless of breed, age, or other factors. Rabbits in multi-rabbit facilities including breeding operations, shelters, and rescues face amplified risk because RHDV2 spreads rapidly through populations. Outdoor-housed rabbits have greater exposure to wild lagomorphs, insect vectors, and contaminated environments. Geographic location significantly affects risk, with rabbits in the western United States where RHDV2 is endemic facing ongoing elevated exposure compared to areas without confirmed cases—though the virus continues to spread. Show rabbits and those attending gatherings with multiple rabbit populations have increased exposure opportunities. Young kits in affected facilities face high mortality because they lack the age-based protection that existed with RHDV1.

Vaccination recommendations apply universally across all breeds and ages once rabbits reach appropriate vaccination age. Every domestic rabbit should be vaccinated against RHDV2 according to veterinary guidance, with the two-dose initial series followed by annual boosters. Breeders should vaccinate all breeding adults and implement protocols for vaccinating offspring at appropriate ages. Rescue organizations should include RHDV2 vaccination in intake protocols after appropriate quarantine periods. Show rabbits should be fully vaccinated well before any events. Pet owners acquiring rabbits from any source should verify RHDV2 vaccination status and complete or initiate vaccination under veterinary guidance. Given the endemic status of RHDV2 in parts of the United States and its continued spread, vaccination should be considered essential for all pet rabbits nationwide.

Several conditions may co-occur with or develop as complications of RHDV2 infection in the rare rabbits that survive. Secondary bacterial infections can develop as the compromised immune system struggles against opportunistic pathogens. Hepatic lipidosis (fatty liver disease) may occur if surviving rabbits experience prolonged anorexia during illness and recovery, as rabbits are highly susceptible to this condition when they stop eating. GI stasis, the life-threatening slowdown of gut motility, commonly develops secondary to any serious illness in rabbits and may complicate both acute disease and recovery phases. Because rabbits must eat continuously to maintain gut function, the anorexia caused by RHDV2 can trigger secondary GI stasis even before the primary disease becomes fatal. Recovered rabbits that shed virus pose transmission risk to unvaccinated companions, creating management challenges.

Conditions presenting with similar symptoms require consideration in differential diagnosis. RHDV1 causes identical clinical disease but historically spared young rabbits under eight weeks, while RHDV2 affects all ages equally. Myxomatosis in its peracute form can cause rapid death, though classic myxomatosis presents with distinctive head swelling and skin lesions. Bacterial septicemia from severe pasteurellosis or other infections may cause rapid decline. Heat stroke causes sudden collapse and can include hemorrhagic components. Various toxicoses from plants, rodenticides, or chemicals cause liver failure and hemorrhaging. Acute GI stasis complicated by hepatic lipidosis causes death over days rather than hours. Encephalitozoon cuniculi infection can cause neurological signs but follows a more prolonged course. Trauma causing internal bleeding must be considered with sudden death.

Complications and secondary effects of RHDV2 extend beyond immediate health impacts. Environmental contamination persists for months after infected rabbits die or recover, maintaining risk for any unvaccinated rabbits introduced to the area. The virus remains stable on surfaces, in bedding, and in organic material, requiring thorough disinfection with appropriate virucidal agents. Wildlife conservation concerns arise from RHDV2's ability to infect wild lagomorphs including threatened species. Economic impacts on commercial rabbit operations, breeding programs, and rescue organizations can be severe when outbreaks occur. The emotional and psychological impact on owners losing rabbits to RHDV2 is significant, particularly given the sudden nature of death without warning. Surviving rabbits may experience stress and social disruption when bonded companions die, and household dynamics may be permanently altered.